APHA - Aurora Cannabis Is Benefiting From Canada's Messy Legalization
Aurora Cannabis (ACB) ended 2018 down 34.3%, making it the second worst performers of the top 5 largest Canadian cannabis stocks (worst stock is Aphria (APHA) which declined 61.4%). Despite the disappointing performance in 2018, we think the company has a unique opportunity to impress investors when it reports results for the next few quarters. Moreover, we think Aurora has most likely benefited from the unorderly rollout of legalization in Canada last year, which has resulted in severe product shortages and lower consumers' confidence in the legal system. Aurora's latest quarter implied strong